Literature DB >> 4862250

[On the occurrence of beta-hemolytic streptococci in the oropharynx in Bonn school children].

T B Smith, B Heymer, O Haferkamp, M Böckeler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4862250

Source DB:  PubMed          Journal:  Z Med Mikrobiol Immunol        ISSN： 0044-3077


× No keyword cloud information.
  11 in total

1.  CLINICAL APPLICATION OF IMMUNOFLUORESCENCE. I. GROUPING BETA-HEMOLYTIC STREPTOCOCCI.

Authors:  T B SMITH
Journal:  J Bacteriol       Date:  1965-01       Impact factor: 3.490

2.  [STREPTOCOCCUS-CARRIERS AND STREPTOCOCCAL EPIDEMIOLOGY].

Authors:  F KUESTER
Journal:  Dtsch Med Wochenschr       Date:  1965-09-10       Impact factor: 0.628

3.  Experimental studies in rheumatic fever.

Authors:  R F WATSON; S ROTHBARD
Journal:  Prog Cardiovasc Dis       Date:  1962-03       Impact factor: 8.194

4.  Laboratory diagnosis of streptococcal infections.

Authors:  R E WILLIAMS
Journal:  Bull World Health Organ       Date:  1958       Impact factor: 9.408

5.  OBSERVATIONS ON THE EPIDEMIOLOGY OF STREPTOCOCCAL PHARYNGITIS AND THE RELATION OF STREPTOCOCCAL CARRIERS TO THE OCCURRENCE OF OUTBREAKS.

Authors:  A G Kuttner; E Krumwiede
Journal:  J Clin Invest       Date:  1944-03       Impact factor: 14.808

6.  Current knowledge of type-specific M antigens of group A streptococci.

Authors:  R C LANCEFIELD
Journal:  J Immunol       Date:  1962-09       Impact factor: 5.422

7.  Survival of bacteria on swabs.

Authors:  P D Ellner; C J Ellner
Journal:  J Bacteriol       Date:  1966-02       Impact factor: 3.490

8.  THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : I. DEMONSTRATION OF A TYPE-SPECIFIC SUBSTANCE IN EXTRACTS OF STREPTOCOCCUS HAEMOLYTICUS.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1928-01-01       Impact factor: 14.307

9.  TYPING GROUP A HEMOLYTIC STREPTOCOCCI BY M PRECIPITIN REACTIONS IN CAPILLARY PIPETTES.

Authors:  H F Swift; A T Wilson; R C Lancefield
Journal:  J Exp Med       Date:  1943-08-01       Impact factor: 14.307

10.  Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody.

Authors:  A H COONS; M H KAPLAN
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307
View more
  8 in total

Review 1.  [On the xanthofibrogranuloma of the retroperitoneum, the orbita, the mediastinum, the lungs and the liver root and its clinical significance].

Authors:  O Haferkamp
Journal:  Klin Wochenschr       Date:  1968-01-01

2.  [Clinical use of immunofluorescence. II. Preparation of the reagents needed for the immunofluorescence method and localization of bacteria in the tissues].

Authors:  T B Smith; B Heymer; O Haferkamp
Journal:  Z Med Mikrobiol Immunol       Date:  1966

3.  [Comparative electron microscopical and biochemical studies on the activity of a Streptomyces albus endo-N-acetyl-muramidase on the streptococcal cell wall].

Authors:  B Heymer; H Schäfer; O Haferkamp
Journal:  Med Microbiol Immunol       Date:  1973-03-08       Impact factor: 3.402

4.  [Group A serotypes of beta-hemolytic streptococci in West Germany].

Authors:  T B Smith
Journal:  Klin Wochenschr       Date:  1970-08-15

5.  Induction of granulomatous hepatitis in mice infected with group A streptococci and treated with penicillin.

Authors:  R Spanel; J Galle; B Heymer; O Haferkamp; W C Schmidt
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1974

6.  Persisting streptococcal cell-wall components in murine chronic pyogenic nephritis.

Authors:  W Schachenmayr; B Heymer; O Haferkamp
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1972

7.  Clinical application of immunofluorescence. 3. Identification of Lancefield group B streptococci.

Authors:  T B Smith
Journal:  Infect Immun       Date:  1971-09       Impact factor: 3.441

8.  Inhibition of macrophage migration by nucleotide-containing streptococcal preparations.

Authors:  B Bültmann; B Heymer; W Schachenmayr; O Haferkamp; W C Schmidt
Journal:  Infect Immun       Date:  1973-11       Impact factor: 3.441
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.